Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05034289 · ClinicalTrials.gov registry record · NA
Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT05034289 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 81 participants.
The verdict
NCT05034289, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).
Interventions
- BEHAVIORAL PINPOINT Digital Educational Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2023-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05034289
The ClinicalTrials.gov registry entry for NCT05034289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PINPOINT Digital Educational Tool is the first listed.
NCT05034289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05034289 about?
NCT05034289 is a clinical study titled "Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy". The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a g...
What is the current status of trial NCT05034289?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2021-07-12. Estimated completion is 2023-05-19.
What interventions are being tested in trial NCT05034289?
The interventions under investigation include: PINPOINT Digital Educational Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT05034289?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.